Table 11.
Synthetic Cannabinergic Agonists | Biological Effect(s) and/or Mechanism Of Action | Reference | |
---|---|---|---|
i. | WIN55212-2 (Winthrop)
|
|
[6,58,136,389,390] |
ii. | CP-55940 (Pfizer) |
|
[136] |
iii. | URB-597 (aka KDS-4103) (targets FAAH) |
|
[391] [6] |
iv. | PF-04457845 (Pfizer—targets FAAH) | Pain disorders (including osteoarthritis) | [342] |
v. | V158866 (Pfizer—targets FAAG) | Pain disorders (including osteoarthritis) | [6] |